Transaction · 0001127602-25-002618

Linetsky David

Linetsky David, SVP, LS, reported an open-market or private sale at Phreesia, Inc. involving 500.000000 shares for an estimated $14841.00. Reported holdings after the transaction were 230771.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSVP, LS
PHRPhreesia, Inc.
Filing timeJan 31
Trade dateJan 29, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

PHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PHR since 2025-01-31Filed 581 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001127602-25-002618
Common Stock
Transaction date
Jan 29, 2025
Filed Jan 31, 2025, 09:23 PM · 2d delay
Shares
500 sh
$2.96k per share
Estimated value
-$1.48M
Computed from shares × price
Holdings after
230k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP, Life Sciences

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 18, 2024.

  2. F2

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.595 to $29.88 per share, inclusive. The Reporting Person undertak…

Original filing · 0001127602-25-002618
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PHR